← Eichor
Study identifier: NCT07541521 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC

Condition: Stage IIB-III NSCLC · Sleeve Lobectomy · Robotic Surgery  ·  Sponsor: Shanghai Chest Hospital

PhaseN/A
Planned participants100
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

The goal of this multicenter prospective observational study is to learn about the surgical difficulty and outcomes of robotic-assisted sleeve lobectomy in patients with non-small cell lung cancer (NSCLC) after neoadjuvant chemoimmunotherapy. The main questions it aims to answer are: What is the rate of unsuccessful robotic-assisted sleeve lobectomy after neoadjuvant chemoimmunotherapy? What factors are associated with unsuccessful surgery? How do surgeons subjectively assess intraoperative difficulty across multiple dimensions during these procedures? In this study, unsuccessful surgery is defined as any of the following: conversion to thoracotomy, incomplete (non-R0) resection, or major postoperative complications. Participants who are scheduled to undergo curative-intent robotic-assisted sleeve lobectomy as part of their routine clinical care after neoadjuvant chemoimmunotherapy will be enrolled from multiple centers. Clinical, intraoperative, pathological, and short-term postoperative data will be collected prospectively. In addition, surgeons will be asked to provide a multidimensional subjective assessment of intraoperative difficulty, including factors such as pleural adhesions, hilar fibrosis, nodal matting, fissure completeness, and vascular inflammation or edema, to better characterize the technical challenges of surgery and their association with perioperative outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

Zhigang Li, MD, PhD  ·  0086-021-22200000  ·  zhigang.li@shsmu.edu.cn

Lin Huang, MD, PhD  ·  008618116061178  ·  dr.huang.lin@shsmu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (10)

Fujian Medical University Union HospitalFuzhou, Fujian, ChinaRecruiting
Guangdong Provincial People's HospitalGuangzhou, Guangdong, ChinaRecruiting
Shenzhen People's HospitalShenzhen, Guangdong, ChinaRecruiting
Jiangsu Cancer Institute & HospitalNanjing, Jiangsu, ChinaRecruiting
The Affiliated Hospital of Qingdao UniversityQingdao, Shandong, ChinaRecruiting
Tianjin Medical University Cancer Institute & HospitalTianjing, Tianjing, ChinaRecruiting
Shanghai Chest Hospital, Shanghai Jiao Tong University Medicine of SchoolShanghai, ChinaRecruiting
Hôpital Saint Joseph MarseilleMarseille, FranceRecruiting
University Hospital, RouenRouen, FranceRecruiting
Azienda Ospedaliera di CosenzaCosenza, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07541521